Search

Author/Creator Rubinstein, Larry

1. 2022-RA-464-ESGO A phase i dose escalation and expansion cohort trial of carboplatin and gemcitabine with the ATR inhibitor berzosertib in first or second recurrence platinum sensitive epithelial ovarian, peritoneal, and fallopian tube cancer. (20th October 2022)

Authors:
Wahner Hendrickson, Andrea E; Foster, Nathan; Corr, Bradley R; Duska, Linda; Markham, Merry J; Butler, Kristina; Girda, Eugenia; Miller, Rachel Ware; Arneson, Katherine; Gano, Katherine; Johnson, Janelle; Shapiro, Geoffrey; Rubinstein, Larry; Percy Ivy, S; Kohn, Elise; Adjei, Alex; Kaufmann, Scott
Journal:
International journal of gynecological cancer
Issue:
Volume 32(2022)Supplement 2
Page Start:
A237
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A Comparative Study of Longitudinal Toxicities of Cytotoxic Drugs, Molecularly Targeted Agents, Immunomodulatory Drugs, and Cancer Vaccines. Issue 4 (29th April 2019)

Authors:
Hirakawa, Akihiro; Sudo, Kazuki; Yonemori, Kan; Sadachi, Ryo; Kinoshita, Fumie; Kobayashi, Yumiko; Okuma, Hitomi S.; Kawachi, Asuka; Tamura, Kenji; Fujiwara, Yasuhiro; Rubinstein, Larry; Takebe, Naoko
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 106:Issue 4(2019)
Page Start:
803
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative report. Issue 2 (February 2020)

Authors:
Armstrong, Terri S; Dirven, Linda; Arons, David; Bates, Amanda; Chang, Susan M; Coens, Corneel; Espinasse, Claire; Gilbert, Mark R; Jenkinson, David; Kluetz, Paul; Mendoza, Tito; Rubinstein, Larry; Sul, Joohee; Weller, Michael; Wen, Patrick Y; van den Bent, Martin J; Taphoorn, Martin J B
Journal:
Lancet oncology
Issue:
Volume 21:Issue 2(2020)
Page Start:
e97
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Potential utility of a longitudinal relative dose intensity of molecularly targeted agents in phase 1 dose‐finding trials. Issue 1 (8th December 2017)

Authors:
Hirakawa, Akihiro; Yonemori, Kan; Kinoshita, Fumie; Kobayashi, Yumiko; Okuma, Hitomi S.; Kawachi, Asuka; Tamura, Kenji; Fujiwara, Yasuhiro; Rubinstein, Larry; Harris, Pamela Jo; Takebe, Naoko
Journal:
Cancer science
Issue:
Volume 109:Issue 1(2018)
Page Start:
207
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Small cell lung carcinoma cell line screen of etoposide/carboplatin plus a third agent. (1st August 2017)

Authors:
Teicher, Beverly A.; Silvers, Thomas; Selby, Michael; Delosh, Rene; Laudeman, Julie; Ogle, Chad; Reinhart, Russell; Parchment, Ralph; Krushkal, Julia; Sonkin, Dmitriy; Rubinstein, Larry; Morris, Joel; Evans, David
Journal:
Cancer medicine
Issue:
Volume 6:Number 8(2017:Aug.)
Page Start:
1952
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Systematic review on the use of patient-reported outcome measures in brain tumor studies: part of the Response Assessment in Neuro-Oncology Patient-Reported Outcome (RANO-PRO) initiative. Issue 4 (13th February 2021)

Authors:
Dirven, Linda; Vos, Maartje E; Walbert, Tobias; Armstrong, Terri S; Arons, David; van den Bent, Martin J; Blakeley, Jaishri; Brown, Paul D; Bulbeck, Helen; Chang, Susan M; Coens, Corneel; Gilbert, Mark R; Grant, Robin; Jalali, Rakesh; Leach, Danielle; Leeper, Heather; Mendoza, Tito; Nayak, Lakshm...
Journal:
Neuro-oncology practice
Issue:
Volume 8:Issue 4(2021)
Page Start:
417
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗